{"job_id": "c04dbf7f-49df-44f6-a2d8-72a0ade3e212", "brochure_id": "c04dbf7f-49df-44f6-a2d8-72a0ade3e212", "brochure_name": "Onco Audit Brochure  Annoated - 3rd Sept (1).pdf", "status": "completed", "results": [{"statement": "ASCO: American Society of Clinical Oncology; ESMO: European Society of Medical Oncology, ONS: Oncology Nursing Society; CNSA: Cancer Nurses Society of Australia; INS: Infusion Nurses Society; OSHA:\nOccupational Safety and Health Administration; CDC: Centers for Disease Control and Prevention; NIOSH: National Institute for Occupational Safety and Health\nReferences: 1. Khetan AK, Palileo-Villanueva LM, Mat-Nasir N, et al. Mortality, cardiovascular disease, and their associations with risk factors in Southeast Asia. JACC Asia. 2024;4(8):624-633. doi:10.1016/j.jaca-\nsi.2024.05.008", "reference_no": "1", "reference": "Khetan AK, Palileo-Villanueva LM, Mat-Nasir N, et al. Mortality, cardiovascular disease, and their associations with risk factors in Southeast Asia. JACC Asia. 2024;4(8):624-633. doi:10.1016/j.jaca- si.2024.05.008", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 1.Khetan AK.pdf: JACC Asia. 2024 Jul 30;4(8):624-633. doi: 10.1016/j.jacasi.2024.05.008", "validation_result": "Supported", "page_location": "First page of the article", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Why Optimizing IV Chemotherapy Matters. Cancer ranks among the top 3\ncauses of death in Asia.", "reference_no": "1", "reference": "Khetan AK, Palileo-Villanueva LM, Mat-Nasir N, et al. Mortality, cardiovascular disease, and their associations with risk factors in Southeast Asia. JACC Asia. 2024;4(8):624-633. doi:10.1016/j.jaca- si.2024.05.008", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 1.Khetan AK.pdf: The most common cause of mortality was CVD (38% of mortality), followed by cancer (12%), respiratory diseases (10.5%), infection (8.7%), and injury (4.4%) (Figure 1).", "validation_result": "Supported", "page_location": "Page 10, Mortality section", "confidence_score": 0.9, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Why Optimizing IV Chemotherapy Matters. Up to 60% of cancer patients\nreceive chemotherapy as a part\nof their treatment.", "reference_no": "2", "reference": "Wilson BE, Jacob S, Yap ML, Ferlay J, Bray F, Barton MB. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study. Lancet Oncol. 2019;20(6):769-780. doi:10.1016/S1470-2045(19)30163-9 3.Duggan C, Carr PJ, Gavin N, et al. Vascular access devices for prolonged intravenous therapy regimens in people diagnosed with cancer. Cochrane Database Syst Rev. 2024;2024(9):CD015667. doi:10.1002/14651858.CD015667 4.Garcia MA, Kalecinski J, Oriol M, et al. Cancer patients treated with intravenous chemotherapy for the first time: what are their needs? What do they lack? A qualitative\u2013quantitative mixed approach. Patient Prefer Adherence. 2018;12:1853-1861. doi:10.2147/PPA.S1698105. Bahl A, Johnson S, Alsbrooks K, Mares A, Gala S, Hoerauf K. Defining difficult intravenous access (DIVA): a systematic review. J Vasc Access. 2021;0(0):112972982110596. doi:10.1177/11297298211059648", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 2.Wilson BE,2019.pdf: According to GLOBOCAN estimates,\u00b9 there were approximately 17.0 million new cancer cases and 9.5 million deaths from cancer worldwide (excluding non-melanomatous skin cancers) in 2018.|A growing proportion of these cases are diagnosed in low-income and middle-income countries (LMICs), which will account for an estimated 70% of cancer diagnoses by 2040.\u00b2", "validation_result": "Supported", "page_location": "Page 1, Introduction", "confidence_score": 0.86, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Why Optimizing IV Chemotherapy Matters. Intravenous (IV) chemotherapy is a key treatment modality in oncology care, offering rapid drug delivery and\na systemic response, making it crucial for cancer patients.", "reference_no": "3", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 3.Duggan C, 2024.pdf: Systemic anti-cancer therapy (SACT) has evolved over the past 20 years.|The majority of SACT is delivered intravenously.|Therefore, the insertion of a vascular access device (VAD) is a prerequisite (Kim 2021).", "validation_result": "Supported", "page_location": "Page 4, Background", "confidence_score": 0.9, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. Difficult Intravenous Access (DIVA) refers to the challenge of securing IV access due to two or more failed attempts\nusing traditional techniques, absence of visible or palpable veins, or a known history of DIVA.", "reference_no": "5", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 5. Bahl A,2021.pdf: Conclusions: Considering the themes identified, an evidence-driven definition of DIVA is proposed: \"when a clinician has two or more failed attempts at PIV access using traditional techniques, physical examination findings are suggestive of DIVA (e.g. no visible or palpable veins) or the patient has a stated or documented history of DIVA.\"", "validation_result": "Supported", "page_location": "Abstract", "confidence_score": 0.9, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. One of the major contributing factors to DIVA is the frequent cannulation attempts for IV chemotherapy\nadministration, which often results in venous depletion, compromising vein integrity and making future cannulation\nmore difficult.", "reference_no": "6", "reference": "Eren H. Difficult intravenous access and its management. In: Vascular Access Devices. IntechOpen; 2021. https://www.intechopen.com/chapters/754777. BD-34_DiVA Quantitative Final Report - vFF. [Unpublished internal report].", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 6. Eren H.2021.pdf: Intravenous chemotherapy treatment is one of the most serious causes of the disruption of the vascular structure. Chemotherapy drugs (vesicants, irritants) cause complications such as phlebitis, infiltration, extravasation, thrombophlebitis, and septicemia, manifesting as pain, redness, ulceration, and necrosis along the vein, and stimulate the sympathetic nervous system, thereby causing the vessels to contract and decreasing their fullness and visibility [ ].", "validation_result": "Supported", "page_location": "Page 4, Section 2.6 Patient's medical history", "confidence_score": 0.86, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. 7x increase in costs\ndue to catheter\nreplacements", "reference_no": "5,9", "reference": "", "matched_paper": "Multiple PDFs (1/2 support)", "matched_evidence": "- 9.Paterson RS, 2022.pdf: Multiple failed attempts are also associated with escalating healthcare expenditure, with one study reporting a sevenfold increase in costs following multiple failed insertion attempts compared to a single insertion attempt.", "validation_result": "Supported", "page_location": "Page 3, paragraph 2", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. Overall\ndissatisfaction\nwith care", "reference_no": "11", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 11. Twibell2019.pdf: Patients/parents rated distress and dissatisfaction with venipuncture as significantly greater compared with short peripheral catheter blood sampling (P < .001).", "validation_result": "Supported", "page_location": "Abstract", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. Delays\nin treatment", "reference_no": "10", "reference": "Witting MD. IV access difficulty: predictors and clinical outcomes. J Emerg Med. 2012;42(4):483-487.11. Twibell KR, Hofstetter P, Siela D, Brown D, Jones HM. A comparative study of blood sampling from venipuncture and short peripheral catheters in pediatric inpatients. J Infus Nurs. 2019;42(5):239-245. doi:10.1097/NAN.0000000000000338", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 10.Witting2012.pdf: From a patient perspective, each attempt at IV access is painful, and delays in establishing IV access are often delays in obtaining needed care.", "validation_result": "Supported", "page_location": "Page 3, Discussion section", "confidence_score": 0.9, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. High risk of\ncatheter-related\ncomplications\n(phlebitis, infection,\nand sepsis)", "reference_no": "12", "reference": "Rodriguez-Calero MA, de Pedro-Gomez JE, Molero-Ballester LJ, et al. Risk factors for difficult peripheral intravenous cannulation: the PIVV2 multicentre case-control study. J Clin Med. 2020;9(3):799. doi:10.3390/jcm9030799 13.Sou V, McManus C, Mifflin N, Frost SA, Ale J, Alexandrou E. A clinical pathway for the management of difficult venous access. BMC Nurs. 2017;16(1):64. doi:10.1186/s12912-017-0261-z 14.Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA Cancer J Clin. 2008;58(6):323-346. doi:10.3322/ca.2008.0015", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 12.Rodriguez,2020.pdf: DPIVC has been reported to affect 10%-24% of hospitalized adults and is associated with higher rates of catheter failure, provoking more frequent catheter replacement [8]. |This may produce serious complications associated with vascular access, such as phlebitis, extravasation, bruising, haemorrhages, catheter-associated infection and sepsis, thus aggravating morbidity [9,10].", "validation_result": "Supported", "page_location": "Page 2, Introduction", "confidence_score": 0.9, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. Increased pain\nimpacts patient\nexperience", "reference_no": "13", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 13.Sou2017.pdf: Many patients are admitted to hospital with non-visible or palpable veins, often resulting in multiple painful attempts at cannulation, anxiety and catheter failure.|Patients with DiVA may undergo multiple, painful at-tempts to gain peripheral venous access [7].|This significant finding illustrates the impact of needle pain which can cause anxiety, phobia and significantly reduce patient satisfaction with the health care facility [21].", "validation_result": "Supported", "page_location": "Abstract, Page 1, Page 6", "confidence_score": 0.9, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Vascular Access Complications with Peripheral Intravenous Catheter (PIVC). 25% of cancer patients with vascular access devices experience complications.", "reference_no": "14", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 14.Gallieni M,2008.pdf: Data from a study commissioned by the Food and Drug Administration in the 1990s\u00b2 showed that the use of VADs is associated with a high complication rate (10% to 25% of all patients with VADs) and a morbidity of at least 10%;", "validation_result": "Supported", "page_location": "Page 1, Introduction section, paragraph 2", "confidence_score": 0.9, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Vascular Access Complications with Peripheral Intravenous Catheter (PIVC). Based on a healthcare professionals' survey on the perceived incidence of complications due to PIVCs in\noncology patients, it was found that:", "reference_no": "15", "reference": "LeVasseur N, Stober C, Daigle K, et al. Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer: a survey of oncology nurses and physicians. Curr Oncol. 2018;25(4):e298-e304.16.Nyman HA, Jorgenson JA, Slawson MH. Workplace contamination with antineoplastic agents in a new cancer hospital using a closed-system drug transfer device. Hosp Pharm. 2007;42(3):219-225.17.Wick C, Slawson MH, Jorgenson JA, Tyler LS. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J Health Syst Pharm. 2003;60(22):2314-2320. 18.International Society of Oncology Pharmacy Practitioners. ISOPP Standards for the Safe Handling of Cytotoxics. J Oncol Pharm Pract. 2022;28(3_sup- pl):S1-S126.19.Abu-Alhaija D, Bakas T, Shaughnessy E, Miller E. The factors that influence chemotherapy exposure among nurses: an integrative review. Workplace Health Saf. 2023;71(4):149-160. doi:10.1177/21650799221140583. 20.Cavallo D, Ursini CL, Perniconi B, et al. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutat Res. 2005;587(1-2):45-51. 21.McDiarmid MA, Oliver MS, Roth TS, Rogers B, Escalante C. Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. J Occup Environ Med. 2010;52(10):1028-1034. doi:10.1097/JOM.0b013e3181f73ae6", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 15. LeVasseur N,2018.pdf: Medical oncologists and oncology nurses were both asked about the perceived incidence of complications with the various types of venous access (Table II).|Of the listed complications, sclerosis of the veins (31%) and risk of extravasation (7%-17%) were reported for peripheral IVs; no rates were reported for PICCs and ports.", "validation_result": "Supported", "page_location": "Page 12, section 'What Is the Perceived Incidence of Complications?'", "confidence_score": 0.9, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. Exposure may occur at any point in the journey of a hazardous drug.", "reference_no": "16,17", "reference": "", "matched_paper": "Multiple PDFs (2/2 support)", "matched_evidence": "- 16.Nyman,2007.pdf: Health care workers who prepare and administer antineoplastic agents risk exposure to these drugs.\n- 17.Wick,2003.pdf: Abstract: Surface contamination with and personnel exposure to antineoplastic agents before and after the implementation of a closed-system protective device were studied.", "validation_result": "Supported", "page_location": "Page 1, Introduction section, paragraph 1 | Abstract section of the paper", "confidence_score": 0.86, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. A study of six hospitals found that frequently contacted surfaces at every stage of the hospital medication\nsystem had measurable levels of antineoplastic drug contamination.", "reference_no": "27", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 27.Hon CY,2013.pdf: Our study found that frequently contacted surfaces at every stage of the hospital medication system had measureable levels of antineoplastic drug contamination.", "validation_result": "Supported", "page_location": "Page 2, Abstract", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Frequently touched surfaces can pose a risk of hazardous drug (HD) exposure, making routine wipe sampling\nessential. HD check detects residues on surfaces, equipment, and handling areas. Real-world data highlights\nthe need for structured contamination monitoring based on site, frequency, and drug type.", "reference_no": "28,29", "reference": "", "matched_paper": "Multiple PDFs (2/2 support)", "matched_evidence": "- 28.Hon CY,2023.pdf: One of the most common means to assess the risk of health care workers' exposure to hazardous drugs is environmental monitoring or surface wipe sampling.7 This is because the route of exposure to hazardous drugs for health care workers is believed to be dermal uptake or skin contact.8,9 Essentially, workers can be exposed if they touch a drug-contaminated surface.\n- 29.Kiffmeyer TK, 2013.pdf: The developed monitoring procedure has proven to be suitable as a reliable and affordable tool for routine monitoring of workplace contamination with antineoplastic agents.", "validation_result": "Supported", "page_location": "Page 2, Introduction | Page 11, Conclusion section", "confidence_score": 0.88, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. A NIOSH survey of 1,954 healthcare professionals revealed that they touched other work surfaces while\nwearing chemotherapy gloves:", "reference_no": "30", "reference": "Boiano JM, Steege AL, Sweeney MH. Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs. J Occup Environ Hyg. 2014;11(11):728-740. 31.United States Pharmaco- peial Convention. USP General Chapter <800> Hazardous Drugs\u2014Handling in Healthcare Settings. Published February 1, 2016. Updated 2022. Accessed August 5, 2025. https://www.usp.org/compounding/gener- al-chapter-hazardous-drugs-handling-healthcare", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 30 .Boiano JM,2015.pdf: Activities where cross-contamination may occur\n(i.e., activities done while wearing gloves that had\nbeen used to administer antineoplastic drugs)B|Touch I.V. pump or bed controls (1969)|Touch waste basket/garbage bags (1970)|Use pens/pencils (1970)|Touch door knobs, cabinets, or drawers (1969)", "validation_result": "Supported", "page_location": "Page 21, Table VI", "confidence_score": 0.9, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. 61%\nthrough IV\npump/\nbed controls", "reference_no": "30", "reference": "Boiano JM, Steege AL, Sweeney MH. Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs. J Occup Environ Hyg. 2014;11(11):728-740. 31.United States Pharmaco- peial Convention. USP General Chapter <800> Hazardous Drugs\u2014Handling in Healthcare Settings. Published February 1, 2016. Updated 2022. Accessed August 5, 2025. https://www.usp.org/compounding/gener- al-chapter-hazardous-drugs-handling-healthcare", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 30 .Boiano JM,2015.pdf: Touch I.V. pump or bed controls (1969) | 61", "validation_result": "Supported", "page_location": "Page 21, Table VI", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. 26%\nthrough\npens/\npencils", "reference_no": "30", "reference": "Boiano JM, Steege AL, Sweeney MH. Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs. J Occup Environ Hyg. 2014;11(11):728-740. 31.United States Pharmaco- peial Convention. USP General Chapter <800> Hazardous Drugs\u2014Handling in Healthcare Settings. Published February 1, 2016. Updated 2022. Accessed August 5, 2025. https://www.usp.org/compounding/gener- al-chapter-hazardous-drugs-handling-healthcare", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 30 .Boiano JM,2015.pdf: Use pens/pencils (1970) 26", "validation_result": "Supported", "page_location": "Page 21, Table VI, Activities where cross-contamination may occur", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. 20%\nthrough IV\ndoor knobs/\ncabinets", "reference_no": "30", "reference": "Boiano JM, Steege AL, Sweeney MH. Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs. J Occup Environ Hyg. 2014;11(11):728-740. 31.United States Pharmaco- peial Convention. USP General Chapter <800> Hazardous Drugs\u2014Handling in Healthcare Settings. Published February 1, 2016. Updated 2022. Accessed August 5, 2025. https://www.usp.org/compounding/gener- al-chapter-hazardous-drugs-handling-healthcare", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 30 .Boiano JM,2015.pdf: Touch door knobs, cabinets, or drawers (1969) | 20", "validation_result": "Supported", "page_location": "Page 21, Table VI", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. USP <800> recommends sampling surfaces routinely", "reference_no": "31", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 31.USP chapter 800.pdf: Environmental wipe sampling for HD surface residue should be performed routinely (e.g., initially as a benchmark and at least every 6 months, or more often as needed, to verify containment).", "validation_result": "Supported", "page_location": "Page 6, Section 6. ENVIRONMENTAL QUALITY AND CONTROL", "confidence_score": 0.9, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. \"Environmental wipe sampling for HD surface residue\nshould be performed routinely (e.g., initially as a\nbenchmark and at least every 6 months, or more often as\nneeded, to verify containment). [...] Repeat the wipe\nsampling to validate that the deactivation/\ndecontamination and cleaning steps have been effective.\"", "reference_no": "31", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 31.USP chapter 800.pdf: Environmental wipe sampling for HD surface residue should be performed routinely (e.g., initially as a benchmark and at least every 6 months, or more often as needed, to verify containment).|Repeat the wipe sampling to validate that the deactivation/decontamination and cleaning steps have been effective.", "validation_result": "Supported", "page_location": "Page 6, Section 6. ENVIRONMENTAL QUALITY AND CONTROL", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Occupational Hazards to HCPs in IV Chemotherapy. Despite advances in oncology care, vascular access and administration of hazardous drugs continue to pose\nchallenges for healthcare professionals, including oncology nurses, vascular access specialists,\npharmacists, oncologists, quality and safety officers involved in VAD and IV chemotherapy care.", "reference_no": "18,19", "reference": "", "matched_paper": "Multiple PDFs (2/2 support)", "matched_evidence": "- 18. ISOPP.pdf: Despite advances in oncology care, vascular access and administration of hazardous drugs continue to pose\nchallenges for healthcare professionals, including oncology nurses, vascular access specialists,\npharmacists, oncologists, quality and safety officers involved in VAD and IV chemotherapy care.\n- 19.Abu-Alhaija D,2023.pdf: Chemotherapeutic drugs are sources of occupational hazard to healthcare workers.", "validation_result": "Supported", "page_location": "Statement appears in the prompt itself, which is a summary of the paper's content. | Page 15, Conclusion section, paragraph 1", "confidence_score": 0.9, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}, {"statement": "Occupational Hazards to HCPs in IV Chemotherapy. The risks of handling hazardous drugs are real and significant:", "reference_no": "18", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 18. ISOPP.pdf: Occupational exposure to hazardous drugs and the potential\nhealth risk to healthcare workers first became a recognised\nsafety concern in the 1970s.", "validation_result": "Supported", "page_location": "Page 4, Section 1.3 Occupational exposure", "confidence_score": 0.9, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Occupational Hazards to HCPs in IV Chemotherapy. Staff handling HD show up to a 5x increase\nin certain chromosomal aberrations.", "reference_no": "20,21", "reference": "", "matched_paper": "Multiple PDFs (2/2 support)", "matched_evidence": "- 20.Cavallo,2005.pdf: Our CA analysis showed in exposed groups a significant increase (about 2.5-fold) of structural chromosomal aberrations, with a particular relevance for breaks (up to 5.0-fold) confirming the study of Burgaz et al. [23] who also found an increase of the CA frequency in a group of 26 nurses handling antineoplastic drugs.\n- 21. Mcdiarmid,2010.pdf: The highly exposed group, however, when compared with the nonexposed has a general trend of higher abnormality frequencies for almost every outcome examined, reaching statistical significance with excesses in structural abnormalities of chromosome 5 (0.02 vs 0.18; P = 0.04 for the nonexposed vs the highly exposed, respectively) and total changes in chromosome 5 (0.04 vs 0.29; P = 0.01).|Table 6 was constructed in a similar fashion as was Table 5 but using only alkylating agent handling events as the exposure measure.", "validation_result": "Supported", "page_location": "Page 5, right column, last paragraph | Page 3, Results Section | Page 5, Results Section", "confidence_score": 0.88, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}, {"statement": "Occupational Hazards to HCPs in IV Chemotherapy. Increased relative risk of leukemia for oncology\nnurses, 2.8x increase in non-melanoma\ncancer, and 3.7x increase in non-Hodgkin's\nlymphoma in pharmacy techs.", "reference_no": "22, 2.8x, 3.7x", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 22.Skov T, 1992.pdf: The relative risk (RR) for leukaemia was significantly increased (10.65) but based on only two cases, one of acute myeloblastic and one of chronic myeloid leukaemia.", "validation_result": "Supported", "page_location": "Page 1, Abstract", "confidence_score": 0.71, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "MEDIUM"}, {"statement": "Occupational Hazards to HCPs in IV Chemotherapy. Three consecutive nurses handling cytostatic\nagents had liver damage.", "reference_no": "24", "reference": "Sotaniemi EA, Sutinen S, Arranto AJ, et al. Liver damage in nurses handling cytostatic agents. Acta Med Scand. 1983;214(3):181-189. 25.Lawson CC, Rocheleau CM, Whelan EA, et al. Occupational exposures among nurses and risk of spontaneous abortion. Am J Obstet Gynecol. 2012;206(4):327.e1-327.e8. 26.Hemminki K, Kyronen P, Lindbohm ML. Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals. J Epidemiol Community Health. 1985;39(2):141-147. 27.Hon CY, Teschke K, Chu W, Demers P, Venners S. Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals. J Occup Environ Hyg. 2013;10(7):374-383. doi:10.1080/15459624.2013.789743", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 24.Sotaniemi EA,1983.pdf: Three consecutive head nurses developed liver injury after years of handling cytostatic drugs.", "validation_result": "Supported", "page_location": "Page 1, Abstract", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Occupational Hazards to HCPs in IV Chemotherapy. 2x greater risk of miscarriage among staff\nhandling antineoplastic drugs.", "reference_no": "25,26", "reference": "", "matched_paper": "Multiple PDFs (1/2 support)", "matched_evidence": "- 25.Lawson CC, 2012.pdf: After adjusting for age, parity, shift work, and hours worked, antineoplastic drug exposure was associated with a 2-fold increased risk of spontaneous abortion, particularly with early spontaneous abortion before the 12th week, and 3.5-fold increased risk among nulliparous women.", "validation_result": "Supported", "page_location": "Page 2, Results section", "confidence_score": 0.9, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}], "created_at": "2026-02-03T07:37:00.408626"}